ARCHIVES

New Treatment For CML Could Be Model for Molecular Target-Based Therapeutics

This article is from The Cancer Letter archive.

Vol. 25 No. 47 | December 10, 1999

Download PDF Visit The Full Archive

Related Articles

NCI Clarifies P01 Grant Application Dates

September 13, 1996

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014

Study Finds That CTC Was Used Correctly In Medicare Patients

April 26, 2013

Fisher, Redmond Removed Fro Official posts At NSABP

May 13, 1994

HEW Money Bills Mark Up Set May 26

May 20, 1977

Other Contract Concepts Approved By DCE Board

March 10, 1989